Theradiag Company Profile

News Articles [ 24 Associated News Articles listed on BioPortfolio]

Theradiag raises EUR 8.2 million in IPO

Diagnostics company Theradiag (Marne La Vallee, France) raised EUR 8.2 million ($10.7 million) through the sale of 1.4 million shares at EUR 5.80 in an IPO underwritten by BIL and Portzamparc. The pri...

Theradiag slips in Euronext trading debut

Diagnostics company Theradiag (Euronext:ALTER) was down EUR 0.14 to EUR 5.66 in its first day of trading Tuesday on NYSE Euronext Paris. Last week, the company raised EUR 8.2 million ($10.6 million) t...

France's Theradiag makes acquisition to gain microRNA tech

French theranostics specialist Theradiag, until recently known as Biomedical Diagnostics, has made its first strategic acquisition, agreeing to buy microRNA technology developer Prestizia. Financial...

Theradiag Receives CE Mark Approval for Two New Lisa Tracker Monitoring Kits in Theranostics

Regulatory News: Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a...

[Theradiag] raises €8.2mm in IPO on NYSE Alternext

[Theradiag] (theranostics and diagnostics for immune conditions, cancer, and infectious diseases) grossed €8.2mm ($10.7mm) through its initial public offering on the NYSE Alternext. The company sold...

Theradiag Receives 3rd CE Mark Approval for New Anti-CCP In-Vitro Diagnostic Kit in Rheumatoid Arthritis

Regulatory News: Theradiag (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it ha...

Theradiag completes IPO

Sebia, Theradiag deal

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [ 1 Associated Companies listed on BioPortfolio]

Theradiag

Theradiag has over 25 years of experience in the autoimmune disorder diagnostics market. It is currently moving into the theranostic testing market to improve biotherapy monitorin...